Brain astrocytes in primary culture from the rat or the mouse have bee
n shown to possess ionotropic and metabotropic glutamatergic receptors
. The activation of both types of receptors is responsible for a rise
in the cytosolic concentration of calcium, while the stimulation of me
tabotropic receptors induces the accumulation of inositol phosphates.
In the present study, it is demonstrated that in striatal astrocytes f
rom mouse embryos, glutamate evokes a release of arachidonic acid. The
nonionotropic receptors involved in this effect appeared to be pharma
cologically distinct from those coupled to phospholipase C: (1) glutam
ate displayed different dose-response curves for the production of ino
sitol phosphates (biphasic: EC(50) = 25 and 300 mu M) and the release
of arachidonic acid (monophasic: EC(50) = 200 mu M); (2) L(+)-2-amino-
4-phosphonobutyric acid (AP4) only antagonized the glutamate-evoked re
lease of arachidonic acid without altering the production of inositol
phosphates; (3) when used at a concentration of 0.1 mM, quisqualate in
duced a higher formation of inositol phosphates than glutamate (2 mM)
while, in contrast to glutamate, it only weakly stimulated arachidonic
acid release when used either at 0.1 mM or 1 mM. L(+)-2-amino-3-phosp
honopropionic acid (AP3) suppressed both responses. The glutamate-evok
ed release of arachidonic acid seems to be oppositely regulated by pro
tein kinases A and C. Indeed, the stimulation of adenylate cyclase by
the B-adrenergic agonist isoproterenol, vasoactive intestinal peptide,
or pretreatment of striatal astrocytes with cholera toxin decreased t
he glutamate-evoked release of arachidonic acid. In contrast, ATP, whi
ch markedly stimulated inositol phosphate production, strongly potenti
ated the glutamate-evoked release of arachidonic acid. An activation o
f protein kinase C could be involved in this potentiation since it was
reproduced by the phorbol ester phorbol 12-myristate 13-acetate (PMA)
, and depressed by staurosporine or when protein kinase C was desensit
ized by long-term pretreatment with PMA.